These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17548778)

  • 1. FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study.
    Kurz MW; Schlitter AM; Klenk Y; Mueller T; Larsen JP; Aarsland D; Dekomien G
    J Geriatr Psychiatry Neurol; 2007 Jun; 20(2):89-92. PubMed ID: 17548778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation.
    Sévin M; Kutalik Z; Bergman S; Vercelletto M; Renou P; Lamy E; Vingerhoets FJ; Di Virgilio G; Boisseau P; Bezieau S; Pasquier L; Rival JM; Beckmann JS; Damier P; Jacquemont S
    J Med Genet; 2009 Dec; 46(12):818-24. PubMed ID: 19542082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism, FXTAS, and FMR1 premutations.
    Toft M; Aasly J; Bisceglio G; Adler CH; Uitti RJ; Krygowska-Wajs A; Lynch T; Wszolek ZK; Farrer MJ
    Mov Disord; 2005 Feb; 20(2):230-3. PubMed ID: 15390127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).
    Van Dam D; Errijgers V; Kooy RF; Willemsen R; Mientjes E; Oostra BA; De Deyn PP
    Behav Brain Res; 2005 Jul; 162(2):233-9. PubMed ID: 15876460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease.
    Costa A; Gao L; Carrillo F; Cáceres-Redondo MT; Carballo M; Díaz-Martín J; Gómez-Garre P; Sobrino F; Lucas M; López-Barneo J; Mir P; Pintado E
    Parkinsonism Relat Disord; 2011 May; 17(4):281-4. PubMed ID: 21257332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
    Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
    Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease.
    Sinforiani E; Zangaglia R; Manni R; Cristina S; Marchioni E; Nappi G; Mancini F; Pacchetti C
    Mov Disord; 2006 Apr; 21(4):462-6. PubMed ID: 16228998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X-associated tremor/ataxia syndrome: intrafamilial variability and the size of the FMR1 premutation CGG repeat.
    Capelli LP; Gonçalves MR; Kok F; Leite CC; Nitrini R; Barbosa ER; Vianna-Morgante AM
    Mov Disord; 2007 Apr; 22(6):866-70. PubMed ID: 17290448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
    Gleicher N; Weghofer A; Oktay K; Barad DH
    Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive decline in early Parkinson's disease.
    Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
    Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.